You got that right striperman!! But for now, having increased revenues come in from ScRelistor provides a solid cash source to lower losses until that happens. Too bad we have to wait until 2016 until Oral Relistor approval as that alone could bring PGNX closer to cash positive, and the $50 million milestone that comes with it isn't swiss cheese.
Wow, what a truly absurd post. DNDN and SNTA are nothing alike. Provenge is a very labor intensive treatment with high upfront costs and suited to a single cancer. Ganetespib is has a relatively low side-effect profile which makes it amenable to many combination therapies, and it has indications of being broad anti-cancer agent. The Hsp90i conjugates are quite intriguing. Unfortunately, SNTA management has been horrid. The conjugates have little value until they make into trials, and management has not yet provided any timetable for that.
Hey Janet, yes it has been a while. I thought PGNX should have rinse to close to $10 after the Relistor label expansion and the good news about 1404 on the prostate cancer imaging front as compared to MRI. If PGNX gets to near that level quickly, I may take some off the table. But I am thinking along the lines of Mr Guttman after he found out that The Maltese Falcon he was chasing was a phony. He calmly estimated that another year on the chase was a only a small increase after the 17 years he has been trying to get it was only 5.6% more. My wait hasn't been THAT long, but I am fine with waiting another year or two before cashing in on the bulk of my holdings.
I believe the part about you sitting on a perch squacking, or did you mean squawking? Do you wear your bird pajamas when you start squawking?
Trufflesdrive, I was thinking the same thing. SLXP won't be doing anything in that regard until their own legal problems are resolved.
Oh, thanks for reminding me. I pointEd out that the price was above his prediction and he said his prediction was for the end of the year. If it is there by the end of the year then I will congratulate him on his guess coming out. Anybody making specific price guarantees is deluding themselves, even if one comes true. By the way, I don't care about the price now. I care about the I-Spy trial.
I guess you have trouble reading. When I mentioned SNTA was above his prediction, he said it didn't matter as Jan 1 was the key date. I am just holding him to the standard he put forth. I can play the same game. SNTA will be between in the $4-$5 range by Jan 1st 2016, maybe even higher. Then at any point if it goes above, I will claim victory. In any event, such short term price movements as to where SNTA will be Jan 1st is irrelevant to me.
Fast Track is nothing to get very excited about. Breakthrough designation is the one that investors hope for. I can't tell you anything about the December FDA meeting.
Let's get all the troll's comments in in one post. PGNX will never break $4, watch and learn. PGNX will never hold $4, watch and learn. PGNX will never break $5, watch and learn. PGNX will never hold $5, watch and learn. PGNX will never break $6, watch and learn. PGNX will never hold $6, watch and learn. PGNX will never break $7, watch and learn. PGNX will never hold $7, watch and learn. The high is in for the day, watch and learn. PGNX will close lower, watch and learn.
Now for furute prediconts. PGNX will never break $8, watch and learn. PGNX will never hold $8, watch and learn. PGNX will never break $9, watch and learn. PGNX will never hold $9, watch and learn. PGNX will never break $10, watch and learn. PGNX will never hold $10, watch and learn. Followed by oh, mommy, how did I lose so much money!!!
Someone needs to tell him he has been holding the PGNX price chart upside down. The someone would then have to explain to him that the move from the mid $3s to over $7 is a price RISE, not a price decline as he has been spouting continually during that rise.
guttman, Most people would be ashamed to spread such ignorant comments as "Most treatments are more painful than the disease." and "It is sad how drug companies prey on the emotions of dying people and their families for profit." What is wrong with you?
Oh my God, PGNX might not finish at its high for the day again, but will still end the day higher. Will the horror ever end?
I will feel better once the HSP90i conjugates get into trials. Until then, it is just a concept with pre-clinical support so isn't worth much. For what it is worth, I couldn't resist the latest price drop so bought some more SNTA.